Description KLOW 80mg peptide blend, documented component by component Purity Collective supplies the KLOW 80mg Peptide Blend in a lyophilized vial for qualified laboratory research
Following the success and approval of tirzepatide (Mounjaro, Eli Lilly, Indianapolis, IN, USA) in 2022 by FDA for treatment of T2DM, the SURMOUNT programme investigated its use as an anti-obesity medication in those without diabetes
Woschnagg H, Stollberger C, Finsterer J
This article breaks down the latest legal updates, what they mean for your access to weight loss medication, how tirzepatide compares to other GLP-1 drugs, and what affordable options remain through QuickMD
Giridhar-Gohal, who has spent the last 25 years working in FMCG and retail with global corporations such as Diageo and PepsiCo, says there are opportunities for companies that can develop products that deliver high nutritional value in smaller formats, such as protein-forward snacks, fibre-rich foods that support satiety, portion-controlled products, and nutrient-dense mini-meals or functional beverages
